Landscape Capital Management L.L.C. increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 356.8% during the second quarter, HoldingsChannel.com reports. The fund owned 7,030 shares of the medical equipment provider’s stock after buying an additional 5,491 shares during the quarter. Landscape Capital Management L.L.C.’s holdings in Intuitive Surgical were worth $3,688,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of ISRG. Manchester Financial Inc. bought a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $25,000. Icon Wealth Partners LLC acquired a new position in shares of Intuitive Surgical in the first quarter valued at approximately $26,000. Advisory Alpha LLC acquired a new position in shares of Intuitive Surgical in the first quarter valued at approximately $32,000. Ellis Investment Partners LLC acquired a new position in shares of Intuitive Surgical in the first quarter valued at approximately $34,000. Finally, FTB Advisors Inc. raised its position in shares of Intuitive Surgical by 333.3% in the first quarter. FTB Advisors Inc. now owns 78 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 60 shares during the last quarter. Institutional investors and hedge funds own 86.09% of the company’s stock.

Intuitive Surgical stock traded up $0.71 during trading on Thursday, reaching $501.17. The company had a trading volume of 18,256 shares, compared to its average volume of 640,121. Intuitive Surgical, Inc. has a 12-month low of $430.24 and a 12-month high of $589.32. The business’s 50 day moving average price is $524.60. The stock has a market capitalization of $58.77 billion, a price-to-earnings ratio of 52.69, a price-to-earnings-growth ratio of 3.79 and a beta of 1.12.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 18th. The medical equipment provider reported $3.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.23 by $1.02. Intuitive Surgical had a net margin of 29.95% and a return on equity of 17.35%. The firm had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the previous year, the firm earned $2.76 earnings per share. Intuitive Surgical’s revenue was up 20.9% compared to the same quarter last year. Sell-side analysts expect that Intuitive Surgical, Inc. will post 10.15 earnings per share for the current year.

In related news, VP Marshall Mohr sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $526.11, for a total value of $7,891,650.00. Following the completion of the sale, the vice president now directly owns 20,135 shares in the company, valued at $10,593,224.85. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Reiter Kara Andersen sold 4,120 shares of the business’s stock in a transaction that occurred on Wednesday, July 24th. The shares were sold at an average price of $540.00, for a total transaction of $2,224,800.00. Following the completion of the sale, the senior vice president now owns 7,838 shares of the company’s stock, valued at $4,232,520. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 25,655 shares of company stock valued at $13,552,920. 1.70% of the stock is owned by insiders.

A number of equities analysts have recently weighed in on the stock. BidaskClub raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, June 11th. Citigroup cut their price objective on shares of Intuitive Surgical from $611.00 to $575.00 and set a “buy” rating for the company in a research report on Tuesday, May 14th. UBS Group set a $560.00 price objective on shares of Intuitive Surgical and gave the company a “hold” rating in a research report on Friday, July 19th. ValuEngine lowered shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Friday, July 12th. Finally, BTIG Research reissued a “hold” rating on shares of Intuitive Surgical in a research report on Sunday, April 21st. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and ten have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $579.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Read More: What is a capital gains distribution?

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.